cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lantern Pharma Inc
7 own
6 watching
Current Price
$3.01
$-0.27
(-8.23%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
59.61M
52-Week High
52-Week High
6.20000
52-Week Low
52-Week Low
2.99000
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization59.61M
icon52-Week High6.20000
icon52-Week Low2.99000
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio--
What does the Lantern Pharma Inc do?
We are a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies. Our portfolio of therapies consists of small molecules that others have tried, but failed, to develop into an approved commercialized drug, as well as new compounds that we are developing with the assistance of our A.I. platform and our biomarker driven approach. Our A.I. platform, known as RADR®, currently includes more than 275 million data points, and uses big data analytics (combining molecular data, drug efficacy data, data from historical studies, data from scientific literature, phenotypic data from trials and publications, and mechanistic pathway data) and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that we believe may benefit most from our compounds. We were initially incorporated in the State of Texas in November 2013. In January 2020 we reincorporated in the State of Delaware. Our principal executive office is located at 1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201 and our telephone number is (972) 277-1136. Our website is www.lanternpharma.com.
Read More
How much money does Lantern Pharma Inc make?
News & Events about Lantern Pharma Inc.
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ('AI') company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical stage drug programs, today announced the company has published new...
Business Wire
3 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ('AI') company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical stage drug programs, today announced that the U.S. Food and Drug...
PR Newswire
5 months ago
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial PR Newswire BELTSVILLE, Md., May 3, 2023 BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO...
CNW Group - News Releases
5 months ago
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic Clinical Trial Canada NewsWire BELTSVILLE, Md., May 3, 2023 BELTSVILLE, Md., May 3, 2023 /CNW/ -- Reprocell USA, a CRO...
Business Wire
7 months ago
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it has formed a...
Frequently Asked Questions
Frequently Asked Questions
What is Lantern Pharma Inc share price today?
plus_minus_icon
Can Indians buy Lantern Pharma Inc shares?
plus_minus_icon
How can I buy Lantern Pharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Lantern Pharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Lantern Pharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Lantern Pharma Inc?
plus_minus_icon
What is today’s market capitalisation of Lantern Pharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Lantern Pharma Inc?
plus_minus_icon
What percentage is Lantern Pharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Lantern Pharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.01
$-0.27
(-8.23%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$1.63
$-0.04 (-2.40 %)
ALIGOS THERAPEUTICS INC
ALIGOS THERAPEUTICS INC
$0.81
$0.01 (1.13 %)
Passage Bio Inc
Passage Bio Inc
$0.63
$-0.02 (-3.72 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$2.56
$-0.32 (-11.09 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$1.63
$-0.04 (-2.40 %)
ALIGOS THERAPEUTICS INC
ALIGOS THERAPEUTICS INC
$0.81
$0.01 (1.13 %)
Passage Bio Inc
Passage Bio Inc
$0.63
$-0.02 (-3.72 %)
Taysha Gene Therapies Inc
Taysha Gene Therapies Inc
$2.56
$-0.32 (-11.09 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00